CGEN (Compugen) Other Current Liabilities : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Compugen Other Current Liabilities?

Compugen's other current liabilities for the quarter that ended in Sep. 2024 was $0.00 Mil.

Compugen's quarterly other current liabilities increased from Mar. 2024 ($-0.00 Mil) to Jun. 2024 ($0.00 Mil) but then from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($0.00 Mil).

Compugen's annual other current liabilities declined from Dec. 2021 ($3.30 Mil) to Dec. 2022 ($2.81 Mil) but then increased from Dec. 2022 ($2.81 Mil) to Dec. 2023 ($3.13 Mil).

Compugen Other Current Liabilities Historical Data

The historical data trend for Compugen's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Compugen Other Current Liabilities Chart

Compugen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Compugen Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Compugen Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Compugen Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Compugen's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Compugen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Compugen Ltd (NAS:CGEN) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

CGEN:Israel

Address

26 Harokmim Street, Building D, Azrieli Center, Holon, ISR, 5885849

Website

https://www.cgen.com

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.